Clémentine BODY

Clémentine BODY has a diverse work experience in various organizations. Clémentine started their career at Leem in 2005, where they held positions such as "Head of statistics and economic studies" and "in charge of economic missions and statistical studies" until January 2017. From January 2017 to May 2018, they worked at MSD as a "Pricing and Reimbursement specialist". Clémentine then joined Biogen in May 2018 and worked as a "Senior Market Access Manager" until May 2021. From May 2021 to June 2022, they served as an "Associate Director Public Policies, Government Affairs" at Biogen. In June 2022, they transitioned to Stemline Therapeutics as a "Market Access Director" until May 2023. Currently, Clémentine works as the "Director Projects Transverses et International" at Agence de l'Innovation en Santé since May 2023.

Clémentine BODY attended the Université Claude Bernard Lyon 1 from 2002 to 2003, where they pursued their 5th degree in statistics and modelization. Prior to that, they studied at the Université Joseph Fourier (Grenoble I) from 1999 to 2002, completing their 4th degree in mathematics and computer science. Their high school education was obtained at the Lycée Vaugelas, but no specific information is available regarding the degree obtained or field of study.